VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMNAMN Healthcare Services, Inc.
$38.10$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMNCash Flow

AMN Healthcare Services, Inc. (AMN) Cash Flow Statement

26Y historyFree accessUpdated daily

Operating cash flow swung from $562.5M in 2026Q1 to negative $87.5M in 2026Q3 as working capital outflows of $146.9M outweighed $33.4M of net income, leaving free cash flow margin at -13.6%.

Income StatementBalance SheetCash FlowRatios

AMN Cash Flow Statement

Annual statement

AMN Cash Flow Statement

AMN Healthcare Services, Inc. (AMN) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash from Operations360.57M269.46M320.42M372.17M653.73M305.36M256.83M224.86M226.99M115.26M131.85M57.05M27.68M58.64M60.51M19.31M8.09M98.73M63.69M79.64M54.54M44.09M39.04M65.14M56.85M1.68M-1.59M
Operating CF Margin %-9.87%10.74%9.82%12.47%7.66%10.73%10.12%10.63%5.8%6.93%3.9%2.67%5.8%6.34%2.18%1.17%12.99%5.23%6.84%5.04%6.25%6.21%9.12%7.33%0.32%-0.69%
Operating CF Growth %-317.24%-15.9%-13.9%-43.07%114.09%18.9%14.21%-0.94%96.94%-12.58%131.1%106.13%-52.8%-3.1%213.34%138.74%-91.81%55.01%-20.02%46.02%23.7%12.94%-40.08%14.59%3286.12%205.86%-
Net Income109.02M-95.7M-146.98M210.68M444.05M327.39M70.67M113.99M141.74M132.56M105.84M81.89M33.22M32.93M15.95M-26.27M-51.99M-122.18M34.36M36.53M35.09M22.23M17.35M37.79M52.36M-4.39M-5.2M
Depreciation & Amortization138.81M156.6M173.78M160.93M137.11M103.7M94.19M58.52M41.24M32.28M29.62M20.95M15.99M13.54M14.15M16.42M15.08M13.81M14.44M11.67M10.32M6.18M5.84M4.82M3.84M7.71M3.3M
Stock-Based Compensation34.02M30.68M23.32M18.02M30.07M25.22M20.46M16.24M10.81M10.24M11.4M10.28M7.16M6.13M6.22M7.13M8.28M8.71M9.32M8.39M6.8M142K16.1K874K31.88M31.88M0
Deferred Taxes-18.36M-19.55M0-12.93M-24.61M-16.29M-21.63M913K-667K5.61M-9.42M12.68M11.78M3.03M6.95M-1.79M-10.71M-51.72M-3.37M1.14M18.08M19.02M4.09M6.04M7.29M-8.65M-9.73M
Other Non-Cash Items8.07M96.39M184.39M45.6M67.68M8.84M26.01M16.22M2.25M12.85M11.12M1.58M7.14M1.84M19.51M47.67M57.98M185.6M1.76M2.13M-2.74M4.48M2.44M1.6M-27.58M14.28M27.02M
Working Capital Changes89.01M101.03M85.91M-50.13M-558K-143.49M67.13M18.98M31.61M-78.27M-16.7M-70.33M-47.61M1.16M-2.27M-23.84M-10.56M64.51M7.18M19.77M-13.01M-7.96M9.32M14.02M-10.94M-39.16M-16.98M
Change in Receivables-11M74.75M219.44M224.85M20.04M-585.27M-8.61M5.71M-10.58M-10.64M-57.16M-98.02M-52.13M-8.45M1.39M-29.02M-15.3M88.73M10.41M5.53M-40.6M-474K0-30.15M-39.48M-39.48M0
Change in Inventory00000-256.12M-5.56M-1.93M14.56M-32.63M-3.34M-7.34M-4M4.33M-12.29M5.6M1.16M0-6.91M8.57M23.83M-106.36M0-36.48M-111.42M-118.81M0
Change in Payables27.8M-20.57M0-183.52M0256.12M5.56M1.93M17.15M-7.86M17.7M29.61M6.13M4.34M2.83M3.66M8.94M01.94M1.72M1.18M-1.2M03.66M2.65M2.65M0
Cash from Investing-46.62M4.3M-79.94M-412.49M-170.71M-107.4M-538.17M-291.82M-279.34M-33.45M-257.36M-116.83M-28.23M-47.9M2.96M-1.98M-6.85M-29.25M-48.25M-14.63M-45.68M-115.33M-5.06M-14.01M1.45M-33.78M-94.14M
Capital Expenditures-34.04M-35.63M-80.89M-105.39M-75.83M-53.66M-39.1M-36.46M-36.39M-26.53M-21.96M-27.01M-19.13M-9.05M-5.47M-4.65M-4.17M-3.79M-8.79M-9.15M-9.71M-3.82M-5.06M-13.01M-4.33M-4.5M-2.36M
CapEx % of Revenue0.97%1.3%2.71%2.78%1.45%1.35%1.63%1.64%1.7%1.33%1.15%1.85%1.85%0.89%0.57%0.52%0.6%0.5%0.72%0.79%0.9%0.54%0.8%1.82%0.56%0.87%1.02%
Acquisitions-3.03M65.28M0-292.18M-69.5M-41.26M-476.43M-247.91M-217.36M-1.5M-218.34M-85.07M-14.47M-39.5M00-3.23M0-30.95M-5.48M-35.96M-111.51M0-9.53M-9.53M-12.97M-91.79M
Investments---------------------------
Other Investing1K22K-6.76M-24.9M-26.61M-8.99M-7.66M-13.29M-10.67M-8.62M-5.91M-3M10.38M647K8.43M2.67M553K-25.46M-8.5M0000-1M15.31M-19.09M8K
Cash from Financing-121.47M-295.89M-259.45M10.73M-591.87M-34.9M211.49M136.6M37.51M-77.19M126.29M56.2M-2.1M-783K-61.68M-15.3M-26.45M-53.81M-22.33M-50.92M-23.54M86.52M-34.75M-86.47M-33.82M47.21M95.77M
Debt Issued (Net)-100M-285M-250M456.12M0-21.88M240.54M180M120M-44.06M149.68M57M2.23M-681K-53.73M-12.5M-21.86M-53.65M2.04M-37.92M-21.81M89.11M-36.42M137.37M-662K-128.87M45.18M
Equity Issued (Net)-13.18M-2.09M0-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M000530K000-28.45M-16.29M-10.58M2.32M1.93M-219.21M-33.06M177.34M52M
Dividends Paid000000000000000000000000000
Share Repurchases-13.18M-2.09M0-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M-11.91M-4.45M-2.67M-1.07M000-28.45M-18.51M-37.53M0-110K-219.26M-35.16M00
Other Financing-8.29M-8.8M-9.45M-20.65M-15.1M-10.33M-22.13M-24.7M-15.48M-12.97M-10.13M-796K-4.33M262K-8.48M-2.8M-4.59M-156K4.07M3.29M8.86M-4.9M-258K-4.63M-101K-1.26M-1.41M
Net Change in Cash198.04M-22.13M-18.97M-46.76M-108.84M162.72M-69.97M69.64M-14.57M4.53M1.05M-3.5M-2.51M9.9M1.72M2.08M-25.17M15.74M-7.18M14.07M-14.69M15.2M-779K-35.45M24.48M15.11M43K
Free Cash Flow327.03M233.83M239.53M268.48M572.81M251.69M217.72M188.4M190.61M88.73M109.89M30.04M8.54M49.59M55.04M14.66M3.92M94.94M54.9M70.48M44.82M40.27M33.98M52.13M52.52M-2.82M-3.94M
FCF Margin %9.3%8.56%8.03%7.09%10.92%6.32%9.1%8.48%8.92%4.46%5.78%2.05%0.82%4.9%5.77%1.65%0.57%12.5%4.51%6.06%4.14%5.71%5.4%7.3%6.77%-0.54%-1.71%
FCF Growth %46.79%-2.38%-10.78%-53.13%127.58%15.6%15.56%-1.16%114.81%-19.26%265.79%251.63%-82.77%-9.9%275.34%273.99%-95.87%72.94%-22.11%57.25%11.3%18.53%-34.83%-0.75%1963.91%28.55%-
FCF per Share8.146.076.276.8212.775.244.573.963.921.802.230.620.181.041.180.320.112.911.622.021.301.251.081.311.12-0.09-0.18
FCF Conversion (FCF/Net Income)3.00x-2.82x-2.18x1.77x1.47x0.93x3.63x1.97x1.60x0.87x1.25x0.70x0.83x1.78x3.53x-0.74x-0.16x-0.81x1.85x2.18x1.55x1.98x2.25x1.72x1.09x-0.38x0.31x
Interest Paid48.96M45.11M61.03M48.1M37.52M38.09M22.65M23.73M21.28M17.94M8.06M-5.81M4.6M7.41M13.7M19.67M16.43M7.39M9.6M00000000
Taxes Paid65.8M7.85M28.15M78.26M213.81M106.38M46.26M37.75M30.59M73.75M73.37M-33.13M17.88M18.86M1.86M388K84K5.61M32.95M00000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile working capital swings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Operating Cash Flow Diverges From Earnings

According to the reported quarterly figures, AMN's operating cash flow swung from $562.5M in 2026Q1 to negative $189.9M in 2026Q2 while net income remained positive at $21.2M, a gap that suggests working capital timing rather than earnings power is driving cash generation.

The OCF-to-net-income ratio has been erratic, ranging from roughly -9x to +9x across recent quarters, which makes the ratio itself uninformative and points instead to large swings in receivables and payables. Such dispersion suggests reported earnings are not translating into cash on a consistent basis. Investors should monitor whether the 2026Q1 inflow reverses in subsequent periods, as it may reflect collection of receivables built up earlier rather than durable conversion.

Working Capital Dominates Cash Movements

Based on AMN's reported figures, working capital changes of negative $146.9M in 2026Q3 and negative $215.1M in 2026Q2 outweighed net income of $33.4M and $21.2M, indicating that receivables management is the primary determinant of near-term cash flow.

The magnitude of working capital swings relative to net income suggests that collection timing, and potentially hospital payment delays, are materially influencing reported cash. A sustained build in receivables during a period of declining revenue may indicate customers are stretching payments, which warrants further investigation via the allowance for doubtful accounts and DSO trends. The reversal in 2026Q1 suggests this dynamic is cyclical rather than structural, but the consistency of outflows in recent quarters is a concern.

Free Cash Flow Negative Across Recent Quarters

As reported in financial statements, AMN's free cash flow was negative $97.3M in 2026Q3 and negative $198.5M in 2026Q2, with FCF margins of negative 13.6% and negative 29.5%, respectively, following a positive $555.2M quarter in 2026Q1.

The sharp reversal from a strong Q1 inflow to two consecutive large outflows suggests FCF is highly sensitive to working capital rather than underlying operating profitability. Capital expenditure remains modest at roughly 0.5% to 1.5% of revenue in recent quarters, so the FCF deterioration is not driven by investment spending. Investors should view the Q1 2026 result with caution, as it may not represent a sustainable run rate.

Light Capital Intensity Limits Investment Drag

Based on EDBL-style reported figures, AMN's capital expenditures have stayed between 0.5% and 3.7% of revenue over the past ten quarters, with recent quarters near 1.3%, indicating a low-capital-intensity staffing model.

CapEx running below depreciation of roughly $32M to $44M per quarter suggests the company is not reinvesting heavily in its asset base, which is consistent with a services business where technology spend may be partially expensed. The decline in CapEx from 3.7% of revenue in 2024Q2 may reflect cost discipline during the revenue contraction. Whether this underinvestment compromises the VMS and technology platforms over time warrants monitoring.

Cumulative Cash Reality Versus Reported Profit

According to reported quarterly figures, cumulative net income across the sampled ten quarters is negative when including the large 2024Q4 and 2025Q2 losses, while cumulative operating cash flow is substantially positive, a divergence that depends heavily on the timing of the 2026Q1 inflow.

Over the sampled window, cash generation has exceeded reported earnings in aggregate, which may reflect non-cash charges such as amortization and impairments embedded in the net losses. The divergence is not unambiguous, however, because the strong 2026Q1 inflow carries much of the weight in that comparison. Investors should treat the cumulative picture as dependent on whether the working capital release proves durable.

What the Cash Flow Statement May Obscure

Based on reported figures, AMN's stock-based compensation of $8.5M to $9.9M per quarter and amortization embedded in D&A of roughly $32M to $44M per quarter may flatter operating cash flow relative to the economic cost of the business, warranting scrutiny of underlying cash quality.

Stock-based compensation is a non-cash add-back that reduces reported net income impact but represents a real economic cost to shareholders through dilution, so OCF may overstate sustainable cash generation to a degree. Large acquisition-related intangibles inflate D&A, and the gap between D&A and CapEx suggests reinvestment may lag the amortization base over time. The 2026Q1 inflow may also reflect collection of receivables that management could have accelerated, so investors should verify whether the release is sustainable before extrapolating it.

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

How much cash does AMN Healthcare Services, Inc. (AMN) generate from operations?

AMN Healthcare Services, Inc. (AMN) generated $269.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is AMN Healthcare Services, Inc.'s free cash flow?

AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is AMN Healthcare Services, Inc.'s capital expenditure (CapEx)?

AMN Healthcare Services, Inc. (AMN) spent $35.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does AMN Healthcare Services, Inc. distribute cash to shareholders?

In 2025, AMN Healthcare Services, Inc. (AMN) spent $2.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.